Talphera (TLPH) Return on Capital Employed Growth (3y) (2014 - 2026)
Talphera (TLPH) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 480.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1,902.00 |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | 1,899.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,899.00 |
| Dec 31, 2025 | 3,499.00 |
| Sep 30, 2025 | 2,273.00 |
| Jun 30, 2025 | -2,462.00 |
| Mar 31, 2025 | -3,338.00 |
| Dec 31, 2024 | -2,626.00 |
| Sep 30, 2024 | -1,906.00 |
| Jun 30, 2024 | -1,356.00 |
| Mar 31, 2024 | -1,848.00 |
| Dec 31, 2023 | 1,630.00 |
| Sep 30, 2023 | 1,395.00 |
| Jun 30, 2023 | 953.00 |
| Mar 31, 2023 | 911.00 |
| Dec 31, 2022 | -2,192.00 |
| Sep 30, 2022 | -3,564.00 |
| Jun 30, 2022 | -3,374.00 |
| Mar 31, 2022 | -2,129.00 |
| Dec 31, 2021 | -2,064.00 |
| Sep 30, 2021 | -552.00 |
| Jun 30, 2021 | 688.00 |